You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drugs Containing Excipient (Inactive Ingredient) POVIDONE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POVIDONE excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
ER Squibb & Sons LLC BARACLUDE entecavir 0003-1611 POVIDONE
Eli Lilly and Company EVISTA raloxifene hydrochloride 0002-4184 POVIDONE
ER Squibb & Sons LLC PRAVACHOL pravastatin sodium 0003-5178 POVIDONE
Merck Sharp & Dohme LLC SEGLUROMET ertugliflozin and metformin hydrochloride 0006-5369 POVIDONE 2030-10-21
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 4 of 4 entries

Generic drugs containing POVIDONE excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: Povidone

Introduction

Povidone, a versatile and widely used pharmaceutical excipient, plays a crucial role in various drug formulations and medical applications. This article delves into the market dynamics and financial trajectory of povidone, highlighting its current status, growth drivers, and future outlook.

Market Size and Growth

The global povidone iodine market, which is a key application of povidone, was valued at $152.6 million in 2021. It is projected to reach $242.2 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2031[4].

Key Drivers of Growth

Several factors are driving the growth of the povidone market:

Increased Awareness of Hygiene and Infection Prevention

The heightened awareness about hygiene and infection prevention, particularly in the healthcare sector, has significantly boosted the demand for povidone iodine. Its broad-spectrum antimicrobial properties make it essential for wound care, surgical procedures, and personal hygiene products[4].

Demand from the Pharmaceutical Industry

The pharmaceutical industry's increasing demand for antiseptic and disinfectant products is another major driver. Povidone iodine's effectiveness in killing germs and harmful bacteria has made it a critical component in preventing hospital-acquired diseases[4].

COVID-19 Impact

The COVID-19 pandemic has accelerated the demand for povidone iodine due to the increased need for instrument sterilization. This surge in demand is expected to continue as healthcare facilities maintain stringent infection control measures[4].

Market Segmentation

The povidone iodine market can be segmented based on formulation type and application:

Formulation Type

  • Scrub
  • Topical Solution
  • Ointments
  • Others

Application

  • Skin Sterilization
  • Instrument Sterilization
  • Disinfectant
  • Others

Instrument sterilization is expected to drive the adoption of povidone iodine, given its critical role in maintaining sterile environments in healthcare settings[4].

Regional Outlook

The demand for povidone iodine varies by region, with significant growth anticipated in areas with high healthcare standards and stringent infection control protocols.

North America and Europe

These regions are expected to witness steady growth due to the established healthcare infrastructure and the ongoing need for effective antiseptic solutions.

Asia Pacific, Middle East, and Africa

These regions are likely to experience faster growth due to expanding healthcare needs, increasing awareness of hygiene, and the development of healthcare infrastructure[4].

Competitive Landscape

The povidone iodine market is competitive, with several established players:

Key Players

  • 3M Company
  • Avrio Health L.P.
  • BASF SE

These companies are investing in research and development to enhance the efficacy and application range of povidone iodine products[4].

Financial Performance and Projections

The financial trajectory of the povidone iodine market is promising, driven by the increasing demand and expanding applications.

Revenue Growth

The market is expected to grow from $152.6 million in 2021 to $242.2 million by 2031, representing a CAGR of 4.7% during the forecast period[4].

Investment and Research

Companies are investing heavily in research to develop new formulations and applications of povidone iodine. This includes enhancing its antimicrobial properties and exploring new uses in wound care and surgical procedures.

Challenges and Opportunities

While the market for povidone iodine is growing, there are several challenges and opportunities to consider:

Regulatory Compliance

Ensuring compliance with regulatory standards is crucial. Companies must adhere to strict guidelines set by health authorities to maintain the quality and safety of povidone iodine products.

Innovation and R&D

Continuous innovation and research are essential to stay competitive. Developing novel applications and improving existing formulations can open up new market opportunities.

Market Expansion

Strategic partnerships and expansions into new regions can help companies tap into unmet medical needs and capitalize on growing healthcare markets.

Key Takeaways

  • The povidone iodine market is expected to grow at a CAGR of 4.7% from 2022 to 2031.
  • Increased awareness of hygiene and infection prevention drives demand.
  • The pharmaceutical industry's need for antiseptic solutions is a significant growth driver.
  • COVID-19 has accelerated demand for instrument sterilization.
  • Key players include 3M Company, Avrio Health L.P., and BASF SE.
  • Regional growth varies, with Asia Pacific, Middle East, and Africa showing faster growth.

FAQs

  1. What is the current market size of the povidone iodine market?

    • The global povidone iodine market was valued at $152.6 million in 2021[4].
  2. What is the projected growth rate of the povidone iodine market?

    • The market is expected to grow at a CAGR of 4.7% from 2022 to 2031[4].
  3. What are the primary applications of povidone iodine?

    • Primary applications include skin sterilization, instrument sterilization, and use as a disinfectant[4].
  4. How has the COVID-19 pandemic impacted the demand for povidone iodine?

    • The pandemic has increased the demand for povidone iodine due to the heightened need for instrument sterilization[4].
  5. Who are the key players in the povidone iodine market?

    • Key players include 3M Company, Avrio Health L.P., and BASF SE[4].

Sources

  1. Allied Market Research - Povidone Iodine Market Size & Share | Forecast Report 2031[4]
  2. Grand View Research - Excipients Market Size, Share & Trends Analysis Report 2030[1]
  3. SkyQuestT - Nutraceutical Excipients Market Size, Share, Growth Analysis[3]
  4. Mallinckrodt Investor Relations - Untitled - Investor Relations[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.